Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hemgenix
Pharma
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
A small patient population, a wait-and-see attitude and a “fairly significant” infrastructure barrier have slowed CSL's gene therapy rollout.
Angus Liu
Apr 11, 2025 10:32am
UniQure sells gene therapy manufacturing facility to Genezen
Jul 1, 2024 10:46am
Pfizer charges $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
Record plasma collections spark a revenue boost for CSL
Aug 16, 2023 11:32am
UK's NICE unsure about CSL's pricey gene therapy Hemgenix
Aug 2, 2023 8:42am
After Hemgenix approvals, uniQure inks $400M sale of royalties
May 15, 2023 3:10pm
